1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with masoprocol in 54 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (masoprocol) | Trials (masoprocol) | Recent Studies (post-2010) (masoprocol) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,527 | 8 | 163 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | masoprocol (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3.5 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 3.5 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (61.11) | 18.7374 |
| 1990's | 21 (38.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, KB; Akley, NJ; Glasgow, WC | 1 |
| Kimura, K; Mochizuki, K; Ohta, M; Shiota, M; Sugano, T | 1 |
| DeBuysere, MS; Gandhi, CR; Olson, MS | 1 |
| Becker, K; Förster, W; Lueddeckens, G; Rappold, R | 1 |
| Aepfelbacher, M; Lux, I; Weber, C; Weber, PC; Zimmer, B | 1 |
| Kurachi, Y; Nakajima, T; Sugimoto, T | 1 |
| Kimura, I; Kimura, M; Kobayashi, S; Nakagawa, M | 1 |
| Clarke, FM; Cock, I; Orozco, C; Perkins, AV | 1 |
| Kaliner, M; Logun, C; Lundgren, JD; Shelhamer, JH | 1 |
| Gimeno, AL; Gimeno, MA; González, E | 1 |
| Braquet, P; Jancar, S; Lauzière, M; Sirois, P; Thériault, P | 1 |
| Borgeat, P; Caon, AC; McColl, SR; Naccache, PH | 1 |
| Calixto, JB; Trebien, HA | 1 |
| Dembinska-Kiec, A; Muller, MK; Peskar, BA; Peskar, BM | 1 |
| Bern, MJ; Berschneider, HM; Karayalcin, SS; Powell, DW; Sturbaum, CW; Wachsman, JT | 1 |
| Beck, G; Brzozowski, T; Drozdowicz, D; Garlicki, J; Konturek, SJ | 1 |
| Bahr, T; Becker, K; Förster, W; Grupe, R; Lueddeckens, G; Schaper, U; Scheuch, DW | 1 |
| Henderson, WR; Martin, TR; Merritt, TL; Raugi, G | 1 |
| Braquet, P; Sirois, P; Soufir, M; Touvay, C; Vilain, B | 1 |
| Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A | 1 |
| Alloatti, G; Benedetto, C; Camussi, G; Emanuelli, G; Massobrio, M; Montrucchio, G; Piva, S; Roffinello, C; Tetta, C; Vigliani, MC | 1 |
| Niwa, Y; Ohashi, T; Ozaki, Y | 1 |
| Arroyave, JL; Gonzalez-Crussi, F; Hsueh, W | 1 |
| Finiasz, M; Gimeno, M; Lazzari, MA; Schattner, MA | 1 |
| Altman, R; Scazziota, A | 1 |
| Alexandre, A; Deana, R; Doni, MG; Padoin, E | 1 |
| Dabiri, GA; Shalit, M; Southwick, FS | 1 |
| Acker, G; Braquet, P; Etienne, A; Hecquet, F; Mencia-Huerta, JM | 1 |
| Bruynzeel, PL; Hamelink, ML; Kijne, AM; Koenderman, L; Kok, PT; Verhagen, J | 1 |
| Anderson, GP; Fennessy, MR; White, HL | 1 |
| Cloutier, S; Jancar, S; Provençal, B; Sirois, P; Thériault, P | 1 |
| Cassina, G; Livio, M; Macconi, D; Morelli, C; Morzenti, G; Remuzzi, G | 1 |
| Dembińska-Kieć, A; Peskar, BA; Peskar, BM | 1 |
| Knee, CD; Krell, RD; Kusner, EJ | 1 |
| Filep, J; Frölich, JC; Küster, LJ | 1 |
| Oda, M; Saito, K; Satouchi, K; Yasunaga, K | 1 |
| Billah, MM; Bryant, RW; Siegel, MI | 1 |
| Detsouli, A; Lefort, J; Vargaftig, BB | 1 |
| Gorman, RR; Lin, AH; Morton, DR | 1 |
| Ford-Hutchinson, AW | 1 |
| Bessin, P; Bonnet, J; Thibaudeau, D | 1 |
| O'Flaherty, JT; Stimler, NP | 1 |
| Bowman, BJ; Smith, RJ | 1 |
| Aguilera, JG; Croxatto, HB; Velasquez, LA | 1 |
| Bates, PJ; Brutinel, WM; Kreofsky, TJ; Limper, AH; Rohrbach, MS; Specks, U | 1 |
| Martin, D; Nadler, JV; Peterson, CL; Thompson, MA | 1 |
| Hasegawa, S; Hirata, A; Hirata, F; Lee, JY; Nomura, A; Sakamoto, T; Uchida, Y | 1 |
| Levine, BA; Olson, MS; Zhou, W | 1 |
| Chen, BN; McLennan, PL; Menadue, MF; Oliver, JR; Rayner, TE | 1 |
| Becker, K; Förster, W; Grupe, R; Lueddeckens, G | 1 |
| Juhn, SK; Kim, Y; Less, C; Lin, J; Ondrey, F | 1 |
| De Matos, IM; Freire-Maia, L; Leite, R; Rocha, OA | 1 |
| Izumi, T; Koyama, S; Kubo, K; Masubuchi, T; Nagai, S; Nomura, H; Sato, E; Takamizawa, A | 1 |
| Quinn, JV; Slotman, GJ | 1 |
54 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and masoprocol
| Article | Year |
|---|---|
Platelet-activating factor provokes release of mucin-like glycoproteins from guinea pig respiratory epithelial cells via a lipoxygenase-dependent mechanism.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Epithelium; Glyceryl Ethers; Guinea Pigs; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Indomethacin; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Mucins; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Trachea | 1992 |
Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins.
Topics: Animals; Chromones; Glycogen; Hot Temperature; Ibuprofen; Isoproterenol; Liver; Male; Mannans; Masoprocol; Opsonin Proteins; Platelet Activating Factor; Prostaglandins; Rats; Rats, Inbred Strains; Receptors, Immunologic; Receptors, Leukotriene; Solubility; Zymosan | 1992 |
Platelet-activating factor-mediated synthesis of prostaglandins in rat Kupffer cells.
Topics: Animals; Bacterial Toxins; Calcium; Cells, Cultured; Cyclic AMP; Enzyme Activation; Ibuprofen; Kupffer Cells; Male; Masoprocol; Platelet Activating Factor; Prostaglandins; Protein Kinase C; Rats; Rats, Inbred Strains | 1992 |
Influence of aminophylline and ketotifen in comparison to the lipoxygenase inhibitors NDGA and esculetin and the PAF antagonists WEB 2170 [correction of 2107] and BN 52021 on endothelin-1 induced vaso- and bronchoconstriction.
Topics: Aminophylline; Animals; Azepines; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Bronchoconstrictor Agents; Diterpenes; Endothelins; Ginkgolides; Guinea Pigs; Ketotifen; Lactones; Lipoxygenase Inhibitors; Lung; Male; Masoprocol; Platelet Activating Factor; Platelet Aggregation Inhibitors; Theophylline; Thromboxane B2; Triazoles; Umbelliferones; Vasoconstriction; Vasoconstrictor Agents | 1991 |
Docosahexaenoic acid inhibits PAF and LTD4 stimulated [Ca2+]i-increase in differentiated monocytic U937 cells.
Topics: Animals; Calcium; Cell Differentiation; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Masoprocol; Monocytes; Phospholipids; Platelet Activating Factor; Proadifen; SRS-A; Tretinoin | 1991 |
Platelet-activating factor activates cardiac GK via arachidonic acid metabolites.
Topics: Animals; Arachidonic Acids; Benzoquinones; Cells, Cultured; Flavanones; Flavonoids; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Guinea Pigs; Heart; Heart Atria; Indomethacin; Lipoxygenase Inhibitors; Masoprocol; Membrane Potentials; Myocardium; Platelet Activating Factor; Potassium Channels; Virulence Factors, Bordetella | 1991 |
Effects of prostaglandin E2 and cyclooxygenase inhibitors on clustering and level of nicotinic acetylcholine receptor in mouse myotubes co-cultured with spinal cord explant.
Topics: Animals; Aspirin; Cell Communication; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Embryo, Mammalian; Indomethacin; Kinetics; Masoprocol; Mice; Mice, Inbred Strains; Muscles; Organ Culture Techniques; Platelet Activating Factor; Receptors, Nicotinic; Spinal Cord | 1991 |
Partial characterization of the PAF-induced soluble factors which mimic the activity of 'early pregnancy factor'.
Topics: Animals; Biological Factors; Calcimycin; Chaperonin 10; Diethylcarbamazine; Masoprocol; Mice; Peptides; Platelet Activating Factor; Pregnancy Proteins; Solubility; Spleen; Stimulation, Chemical; Suppressor Factors, Immunologic; Vasodilator Agents | 1990 |
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway.
Topics: Animals; Bronchi; Cats; Culture Techniques; Glyceryl Ethers; Glycoconjugates; Humans; Ibuprofen; Lipoxygenase; Masoprocol; Platelet Activating Factor; Thiazoles; Trachea; Tritium | 1990 |
A novel enhancing effect of platelet activating factor (PAF) on glucose oxidation in uteri from pregnant rats. Participation of prostaglandins and leukotrienes.
Topics: Animals; Carbon Monoxide; Chromones; Female; Glucose; Indomethacin; Leukotrienes; Masoprocol; Platelet Activating Factor; Pregnancy; Pregnancy, Animal; Prostaglandins; Rats; Rats, Inbred Strains; Uterus | 1990 |
Paf-induced release of spasmogens from guinea-pig lungs.
Topics: Animals; Aspirin; Bronchi; Chromones; Diterpenes; Ginkgolides; Guinea Pigs; In Vitro Techniques; Indoles; Indomethacin; Lactones; Leukotriene B4; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; SRS-A; Trachea | 1989 |
Arachidonic acid-induced mobilization of calcium in human neutrophils: evidence for a multicomponent mechanism of action.
Topics: Arachidonic Acid; Arachidonic Acids; Calcium; Cholera Toxin; Egtazic Acid; Humans; In Vitro Techniques; Leukotriene B4; Masoprocol; Neutrophils; Pertussis Toxin; Platelet Activating Factor; Virulence Factors, Bordetella | 1989 |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom.
Topics: Animals; Captopril; Crotalid Venoms; Dexamethasone; Edema; Hot Temperature; Indomethacin; Male; Masoprocol; Platelet Activating Factor; Prazosin; Quinacrine; Rats; Rats, Inbred Strains; Reference Values; Yohimbine | 1989 |
The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Flow Velocity; Chromatography, High Pressure Liquid; Chromones; Diterpenes; Gastric Mucosa; Ginkgolides; Indomethacin; Lactones; Lipoxygenase Inhibitors; Male; Masoprocol; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Stomach; Thromboxane B2 | 1989 |
Immune system control of rat and rabbit colonic electrolyte transport. Role of prostaglandins and enteric nervous system.
Topics: Animals; Biological Transport; Colon; Electric Conductivity; Electrolytes; Free Radicals; Immune System; Immunoglobulin E; Indomethacin; Intestinal Mucosa; Male; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; Nervous System; Nervous System Physiological Phenomena; Platelet Activating Factor; Prostaglandins; Rabbits; Rats; Rats, Inbred Strains | 1989 |
Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
Topics: Animals; Aspirin; Chromones; Diterpenes; Ethanol; Gastric Mucosa; Ginkgolides; Lactones; Leukotrienes; Male; Masoprocol; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Stomach Ulcer; Stress, Psychological; Taurocholic Acid | 1989 |
Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
Topics: Anaphylaxis; Animals; Aspirin; Diterpenes; Fatty Acids, Unsaturated; Female; Ginkgolides; Imidazoles; Ketotifen; Lactones; Masoprocol; Mice; Naphthalenes; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock; Shock, Septic | 1989 |
Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Topics: Calcimycin; Chemotactic Factors; Chemotaxis, Leukocyte; Humans; Leukotriene B4; Macrophages; Masoprocol; Methionine; Neutrophils; Platelet Activating Factor; Pulmonary Alveoli; Zymosan | 1987 |
Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips.
Topics: Animals; Diterpenes; Ginkgolides; Gossypol; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Lactones; Leukotriene B4; Lung; Male; Masoprocol; Muscle Contraction; Plant Extracts; Platelet Activating Factor; Respiratory Muscles; SRS-A | 1987 |
The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Aspirin; beta-Thromboglobulin; Blood Platelets; Chromonar; Coumarins; Drug Interactions; Epinephrine; Humans; In Vitro Techniques; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles | 1986 |
In vitro oxytocic activity of platelet-activating factor on human myometrium.
Topics: Female; Humans; In Vitro Techniques; Indomethacin; Lipoxygenase; Masoprocol; Myometrium; Oxytocics; Platelet Activating Factor; Pregnancy; Prostaglandin-Endoperoxide Synthases; Uterine Contraction | 1987 |
A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Benzoquinones; Calcimycin; Chemotaxis, Leukocyte; Epoprostenol; Humans; Hydroxides; Hydroxyl Radical; Leukotriene B4; Lipoxygenase Inhibitors; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinones; Tetradecanoylphorbol Acetate; Umbelliferones | 1986 |
Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.
Topics: Alprostadil; Animals; Blood Pressure; Catechols; Chromones; Diethylcarbamazine; Disease Models, Animal; Hematocrit; Indomethacin; Intestines; Ischemia; Leukocyte Count; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Masoprocol; Methacrylates; Necrosis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Salmonella typhi; Thromboxane-A Synthase; Verapamil | 1986 |
Platelet aggregating substance from mononuclear leukocytes.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Coagulation Factors; Catechols; Humans; In Vitro Techniques; Masoprocol; Monocytes; Platelet Activating Factor; Platelet Aggregation | 1986 |
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adenosine; Administration, Oral; Adult; Apyrase; Arachidonic Acids; Aspirin; Catechols; Drug Synergism; Epoprostenol; Humans; Indomethacin; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles; Thromboxane B2; Time Factors; Umbelliferones | 1986 |
Inhibition by antioxidants of agonist evoked cytosolic Ca++ increase, ATP secretion and aggregation of aspirinated human platelets.
Topics: Adenosine Triphosphate; Antioxidants; Aspirin; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Calcium; Egtazic Acid; Ferrous Compounds; Humans; Masoprocol; Organometallic Compounds; Platelet Activating Factor; Platelet Aggregation; Tetradecanoylphorbol Acetate; Thrombin; Vasopressins | 1986 |
Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly.
Topics: Actin Cytoskeleton; Actins; Calcimycin; Calcium; Cytoskeleton; Drug Synergism; Egtazic Acid; Humans; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pertussis Toxin; Platelet Activating Factor; Quinolinium Compounds; Time Factors; Virulence Factors, Bordetella | 1987 |
Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Catechols; Diterpenes; Dose-Response Relationship, Drug; Embryo Implantation; Female; Ginkgolides; Indomethacin; Kinetics; Lactones; Lipoxygenase Inhibitors; Masoprocol; Platelet Activating Factor; Pyrazoles; Rats; Rats, Inbred Strains; Sulfides | 1988 |
Arachidonic acid can induce leukotriene C4 formation by purified human eosinophils in the absence of other stimuli.
Topics: Arachidonic Acid; Arachidonic Acids; Calcium; Calcium Chloride; Eosinophils; Glutathione; Humans; In Vitro Techniques; Masoprocol; Platelet Activating Factor; SRS-A | 1988 |
Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Aspirin; Atropine Derivatives; Bronchi; Female; Guinea Pigs; Histamine; Indomethacin; Lipoxygenase; Male; Masoprocol; Platelet Activating Factor; Pyrazoles; Vagotomy | 1988 |
Mechanism of action of platelet-activating factor on guinea-pig lung parenchyma strips.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Guinea Pigs; Immunoenzyme Techniques; Lung; Masoprocol; Methacrylates; Muscle Contraction; Platelet Activating Factor; Pyrazoles; Sulfonamides; Thromboxane A2; Thromboxane B2 | 1988 |
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Catechols; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lipoxygenase Inhibitors; Masoprocol; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Prostanoic Acids; Quinacrine; Radioimmunoassay; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase | 1985 |
Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed.
Topics: Animals; Chromones; Cysteine; Diterpenes; Ginkgolides; Indomethacin; Lactones; Leukotrienes; Male; Masoprocol; Platelet Activating Factor; Rats; Rats, Inbred Strains; Splanchnic Circulation; SRS-A; Stomach | 1988 |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat.
Topics: Animals; Capillary Permeability; Chromones; Dose-Response Relationship, Drug; Indomethacin; Masoprocol; Methysergide; Nifedipine; Phenoxybenzamine; Phospholipid Ethers; Platelet Activating Factor; Pyrilamine; Rats; Theophylline; Thiazoles | 1987 |
Mechanism of PAF-induced platelet aggregation in man.
Topics: Adult; Aspirin; Blood Platelets; Calcium Channel Blockers; Diterpenes; Female; Ginkgolides; Humans; Kinetics; Lactones; Male; Masoprocol; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2; Trifluoperazine | 1986 |
Polymorphonuclear leukocyte-platelet interactions: acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide.
Topics: Animals; Blood Platelets; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thiazoles | 1986 |
Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2.
Topics: Acetates; Acetic Acid; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Calcimycin; Catechols; Humans; Hydroxyeicosatetraenoic Acids; Lipoxygenase; Masoprocol; Membrane Lipids; Neutrophils; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Trifluoperazine | 1985 |
Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
Topics: Acetophenones; Anaphylaxis; Animals; Catechols; Chromones; Female; Guinea Pigs; Histamine; In Vitro Techniques; Lung; Male; Masoprocol; Muscle Contraction; Platelet Activating Factor; SRS-A | 1985 |
Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Catechols; Cell Aggregation; Chromatography, Gas; Dose-Response Relationship, Drug; Humans; Leukotriene B4; Masoprocol; Mass Spectrometry; Neutrophils; Platelet Activating Factor | 1982 |
Neutrophil aggregating properties of PAF-acether and leukotriene B4.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Catechols; Cell Aggregation; Dose-Response Relationship, Drug; Indomethacin; Leukotriene B4; Male; Masoprocol; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1983 |
Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig.
Topics: Animals; Bronchial Spasm; Catechols; Chromones; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Guinea Pigs; Lipoxygenase Inhibitors; Maleates; Masoprocol; Phenindione; Platelet Activating Factor; Propionates | 1983 |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Blood Platelets; Catechols; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Sulfinpyrazone; Thromboxane B2 | 1983 |
Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Calcium; Catechols; Cyclooxygenase Inhibitors; Cytochalasin B; Cytoplasmic Granules; Humans; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Masoprocol; Muramidase; Neutrophils; Platelet Activating Factor | 1982 |
Possible role of platelet-activating factor in embryonic signaling during oviductal transport in the hamster.
Topics: Animals; Cricetinae; Culture Techniques; Diterpenes; Embryo, Mammalian; Female; Ginkgolides; Indomethacin; Isoquinolines; Lactones; Masoprocol; Ovum Transport; Platelet Activating Factor; Platelet Count; Pregnancy; Pyridinium Compounds; Signal Transduction; Tetrahydroisoquinolines | 1995 |
Comparison of neutrophil chemotactic factor release by human and rabbit alveolar macrophages in response to tannin exposure.
Topics: Animals; Arachidonic Acid; Calcimycin; Cells, Cultured; Chemotaxis, Leukocyte; Culture Media, Conditioned; Humans; Hydrolyzable Tannins; Interleukin-8; Lipoxygenase Inhibitors; Macrophages, Alveolar; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1995 |
Modulation of glutamate and aspartate release from slices of hippocampal area CA1 by inhibitors of arachidonic acid metabolism.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arginine; Aspartic Acid; Female; Flavanones; Flavonoids; gamma-Aminobutyric Acid; Glutamates; Hippocampus; In Vitro Techniques; Indoles; Indomethacin; Masoprocol; omega-N-Methylarginine; Platelet Activating Factor; Potassium; Prostaglandin-Endoperoxide Synthases; Quinacrine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Taurine | 1995 |
IL-1 beta regulates the expression of the Gi2 alpha gene via lipid mediators in guinea pig tracheal muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Gene Expression Regulation; GTP-Binding Proteins; Guinea Pigs; Humans; Hydroxyeicosatetraenoic Acids; Indomethacin; Interleukin-1; Leukotriene D4; Lipids; Lipoxygenase Inhibitors; Masoprocol; Muscle, Smooth; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Recombinant Proteins; Thromboxane A2; Trachea; Vasoconstrictor Agents | 1994 |
Lipid mediator production in acute and chronic pancreatitis in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Chronic Disease; Dinoprostone; Diterpenes; Eicosanoids; Ginkgolides; Lactones; Leukotriene B4; Ligation; Male; Masoprocol; Pancreatic Ducts; Pancreatitis; Platelet Activating Factor; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Thromboxane B2 | 1994 |
Effect of ischaemia and role of eicosanoids in release of atrial natriuretic factor from rat heart.
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Diterpenes; Eicosanoids; Ginkgolides; Heart Rate; Lactones; Male; Masoprocol; Meclofenamic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardium; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Secretory Rate | 1993 |
PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Azepines; Disease Models, Animal; Diterpenes; Eicosanoids; Female; Ginkgolides; Lactones; Masoprocol; Mice; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock; Species Specificity; Triazoles | 1993 |
Effect of lipoxygenase inhibition on mucous glycoprotein secretion from chinchilla middle ear epithelial cells in vitro.
Topics: Acetamides; Animals; Arachidonic Acid; Cells, Cultured; Chinchilla; Cyclooxygenase Inhibitors; Ear, Middle; Epithelium; Glycoproteins; Indomethacin; Lipoxygenase Inhibitors; Masoprocol; Phenyl Ethers; Platelet Activating Factor | 1996 |
Lung oedema induced by Tityus serrulatus scorpion venom in the rat.
Topics: Animals; Aprotinin; Azepines; Capillary Permeability; Cyclooxygenase Inhibitors; Diterpenes; Drug Interactions; Fibrinolytic Agents; Ginkgolides; Hemostatics; Heparin; Hypertension; Injections, Intravenous; Lactones; Leukotrienes; Lipoxygenase Inhibitors; Lung; Male; Masoprocol; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandins; Pulmonary Edema; Rats; Rats, Wistar; Scorpion Venoms; Triazoles | 1997 |
Human lung fibroblasts release chemokinetic activity for monocytes constitutively.
Topics: Adult; Antibodies; Cell Line; Chemokine CCL2; Chemokine CCL5; Chemotaxis, Leukocyte; Cycloheximide; Diethylcarbamazine; Fibroblasts; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Kinetics; Lipoxygenase Inhibitors; Lung; Masoprocol; Monocytes; Platelet Activating Factor; Receptors, Leukotriene B4; T-Lymphocytes; Time Factors; Transforming Growth Factor beta; Trypsin | 1998 |
Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Topics: Aeromonas hydrophila; Animals; Arachidonic Acid; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Eicosanoids; Female; Gram-Negative Bacterial Infections; Heart Diseases; Hemodynamics; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Masoprocol; Oxazoles; Oxygen; Oxygen Consumption; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Swine; Thromboxane A2; Triazoles; Tumor Necrosis Factor-alpha | 1999 |